Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
losartan (cozaar) (1 trial)
rostafuroxin (1 trial)
Essential Hypertension (Phase 2)
Trials (1 total)
Trial APIs (2 total)